Kowalski Petra, Farley Kate M, Lage Hermann, Schneider Erasmus
Wadsworth Center, Empire State Plaza, Albany, NY 12201, USA.
Anticancer Res. 2004 Jul-Aug;24(4):2231-5.
Ribozymes are an effective tool to reduce the mRNA levels of specific target genes. Overexpression of the drug transport protein, ABCG2, has been associated with multidrug resistance in cancer cells.
An expression plasmid encoding a hammerhead ribozyme against the ABCG2 gene was stably transfected into multidrug-resistant MCF7/MX cells that express very high levels of the ABCG2 protein. The effect of the ribozyme was determined by quantitative real-time RT-PCR, Western blot and cytotoxicity assays.
The ribozyme reduced ABCG2 mRNA levels to less than 10% of control values, which resulted in the concomitant reduction of ABCG2 protein levels and sensitization of the cells to mitoxantrone and methotrexate.
The ribozyme used was highly effective in reducing the expression of its target gene, ABCG2, and was able to modulate the associated multidrug-resistant phenotype.
核酶是降低特定靶基因mRNA水平的有效工具。药物转运蛋白ABCG2的过表达与癌细胞的多药耐药性有关。
将编码针对ABCG2基因的锤头状核酶的表达质粒稳定转染到表达高水平ABCG2蛋白的多药耐药MCF7/MX细胞中。通过定量实时RT-PCR、蛋白质印迹和细胞毒性试验确定核酶的作用效果。
核酶将ABCG2 mRNA水平降低至对照值的10%以下,这导致ABCG2蛋白水平随之降低,并使细胞对米托蒽醌和甲氨蝶呤敏感。
所使用的核酶在降低其靶基因ABCG2的表达方面非常有效,并且能够调节相关的多药耐药表型。